Zacks has $0.07 for an estimate. Looking at my initial numbers, I believe RAD will report earnings per share of $0.11 - $0.12, and report $0.38 for fiscal 2015. I hope the shorts push it down so I can buy more shares cheap. GLTA, except Ace.
One: the historically bad winter weather in the north east (f'in global warming!)
Two: RAD's store closure rate is almost zero. Since June-14 RAD has closed a net of 3 stores.
Just some food for thought (for those of you with a brain).
My only concern is that perscription sales were a dismal 2.2% increase. Still a positive gain, but not what I was looking for. GTLA, except Ace.
Drummer, I feel confident in my estimate. I believe January's lower per store revenue was an outlier, just as Novembers higher numbers where. If I'm wrong and the trend is broken, then we could see RAD report Total Drugstore Sales around $2.595B, about a 2.7% increase. Still good, but not what I'd like to see. GLTY
I'm interested on your take on SD's trading pattern the last few days. As I see it, SD put in a bullish reversal inverted hammer/doji today. Still a student at this point, concerning chart patterns. Any insight would be greatly appreciated. GLTY